Exactus Inc. to Present at the 9th Annual LD Micro Invitational

DELRAY BEACH, Fla., May 29, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) (the “Company”), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, today announced that it will be presenting at the 9th Annual LD Micro Invitational on June 4th, 2019 at 10 AM PST / 1PM EST at the Luxe Sunset Bel Air Hotel in Los Angeles, California.  Phil Young, CEO of Exactus, Inc. will be presenting and meeting with investors throughout the day.

EVENT DETAILS
DATE:    9th Annual LD Micro Invitational - June 4th & 5th, 2019
LOCATION:  Luxe Sunset Blvd. Hotel - 11461 Sunset Blvd., Los Angeles, CA 90049
IN ATTENDANCE:          230 companies and over 1,000 individuals

“We are pleased to present the Exactus story to the investment community at the upcoming LD Micro Invitational on June 4th,” states Phil Young, CEO of Exactus, Inc. “The CBD market is estimated to grow to over $22 billion in consumer sales by 2022 and Exactus is well-positioned to take its place as a leader in the market.   Over the last few months the Company has built a tremendous foundation that includes raising over $4 million through friends and family, retired all Company debt, simplified the balance sheet and expanded our Board of Directors and we are now ready to share our story with investors across the globe.”

In addition to the impressive accomplishments above, the Company recently placed a $1 million order of products for inventory, began planting seedlings on the Company’s approximately 200-acre hemp farm in Southwest Oregon, and received an independent fairness opinion on the farming operation showcasing an estimated enterprise value of between approximately $55 million and $74 million.

Interested in learning more about the Company, Phil Young and the Exactus, Inc. team will be meeting with investors across the country during the month of June.  Investors interested in meeting with the team should contact Andrew Johnson for more information on availability at ajohnson@exactusinc.com or by phone at (509) 999-9695.

To learn more about Exactus, Inc. visit the website at www.exactusinc.com.

About Exactus:
Exactus Inc., is pursuing opportunities in hemp derived Cannabidiol, which is more commonly referred to as CBD.  Industrial hemp is a type of cannabis plant containing less than 0.3% THC (tetrahydrocannabinol), which is the psychoactive component of the cannabis plant.  Industrial hemp is cultivated for the plant’s seed, fiber, and extracts.  After 40 years of prohibition, the Agricultural Improvement Act of 2018, known as the 2018 Farm Bill, legalized hemp on the federal level. Hemp production will be regulated by the United States Department of Agriculture (USDA) and the states. As a result, Hemp has generally been removed from the Controlled Substances Act (CSA) and the Drug Enforcement Administration (DEA). A potential risk of growing hemp in the United States is that the entire crop must be destroyed if it tests at a THC percentage greater than 0.3%.

For more information about Exactus: www.exactusinc.com.

About LD Micro:

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Investor Notice
Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks, uncertainties and forward-looking statements described under "Risk Factors" in Item 1A of our most recent Form 10-K for the fiscal year ended December 31, 2018 filed with the Securities and Exchange Commission (the "SEC") on March 29, 2019 and under the heading “Risk Factors” in our Current Report on Form 8-K filed with the SEC on January 14, 2019, and in other periodic and current reports we file with the SEC.  If any of these risks were to occur, our business, financial condition or results of operations would likely suffer. In that event, the value of our securities could decline, and you could lose part or all of your investment. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In addition, our past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results in the future. See "Safe Harbor" below.

Safe Harbor - Forward-Looking Statements
The information provided in this press release may include forward-looking statements relating to future events or the future financial performance of the Company. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "anticipates," "plans," "expects," "intends," "will," "potential," "hope" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon current expectations of the Company and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release relating to the Company may be found in the Company's periodic and current filings with the SEC, including the factors described in the sections entitled "Risk Factors", copies of which may be obtained from the SEC's website at www.sec.gov. Any forward-looking statement speaks only as of the date on which such statement is made, and the Company does not intend to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise.

Company Contact:

Andrew Johnson
Chief Strategy Officer
Exactus Inc.
509-999-9695
ir@exactusinc.com

exactus-logo-color leaf 01.17.19.jpg

Source: Exactus, Inc.